Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04493060
Title Niraparib and Dostarlimab for Treatment of Germline or Somatic BRCA1/2 and PALB2 Mutated Metastatic Pancreatic Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Mayo Clinic
Indications

pancreatic ductal adenocarcinoma

Therapies

Dostarlimab-gxly + Niraparib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST